Glenmark Pharmaceuticals
GLENMARK.NS
#2811
Rank
C$6.24 B
Marketcap
$22.12
Share price
-4.24%
Change (1 day)
25.53%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): $0.15

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $0.15. In 2022 the company made an earnings per share (EPS) of $0.54 a decrease over its 2021 EPS that were of $0.68.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.15-72.39%
2022$0.54-20.18%
2021$0.687.13%
2020$0.6325.72%
2019$0.50-22.01%
2018$0.6430.15%
2017$0.49-34.82%
2016$0.7663.09%
2015$0.479.68%
2014$0.42-26.58%
2013$0.580.51%
2012$0.57